GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 42 | |
SMR RATING 1..100 | 27 | |
PRICE GROWTH RATING 1..100 | 48 | |
P/E GROWTH RATING 1..100 | 53 | |
SEASONALITY SCORE 1..100 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 61% | N/A |
| Stochastic ODDS (%) | 2 days ago 67% | 1 day ago 63% |
| Momentum ODDS (%) | 2 days ago 78% | 1 day ago 44% |
| MACD ODDS (%) | 2 days ago 79% | 1 day ago 73% |
| TrendWeek ODDS (%) | 2 days ago 76% | 1 day ago 64% |
| TrendMonth ODDS (%) | 2 days ago 72% | 1 day ago 49% |
| Advances ODDS (%) | 2 days ago 76% | 4 days ago 62% |
| Declines ODDS (%) | 23 days ago 75% | 1 day ago 54% |
| BollingerBands ODDS (%) | 2 days ago 66% | 1 day ago 48% |
| Aroon ODDS (%) | 2 days ago 76% | 1 day ago 55% |
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with RIO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then RIO could also see price increases.
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | -1.09% | ||
| RIO - EFAV | 50% Loosely correlated | -0.34% | ||
| SAN - EFAV | 49% Loosely correlated | -0.07% | ||
| RTO - EFAV | 44% Loosely correlated | -3.67% | ||
| GSK - EFAV | 43% Loosely correlated | -0.73% | ||
| HLN - EFAV | 39% Loosely correlated | -2.37% | ||
More | ||||